AFP and hepatocellular carcinoma: Lu et al. [43] treated a mouse model of hepatocellular carcinoma (HCC) with exosomes derived from DCs expressing α-fetoprotein (AFP) (DEXAFP) and subsequently elicited a strong antigen-specific immune response and significant tumor growth inhibition, whilst the tumor microenvironment was also improved to some extent.